ClpP drives efficacy and mediates acquired resistance with imipridones ONC201 and ONC206 in glioma in vitro

被引:0
|
作者
Maranto, Cristina
Foster, Scott
Lee, Andrew
Sethna, Phiroze
Allen, Joshua E.
Prabhu, Varun V.
机构
关键词
D O I
10.1158/1538-7445.BRAIN23-A014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A014
引用
收藏
页数:2
相关论文
共 35 条
  • [31] ALLOSTERIC MITOCHONDRIAL CLPP AGONIST ONC206 ALTERS STRESS RESPONSE, METABOLIC AND EPIGENETIC PROFILES TO ELICIT ANTI-CANCER EFFICACY IN HIGH-GRADE GLIOMAS
    Prabhu, Varun V.
    Maranto, Cristina
    Lee, Andrew
    Foster, Scott
    Allen, Joshua E.
    NEURO-ONCOLOGY, 2024, 26
  • [32] CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
    Kawakibi, Abed Rahman
    Tarapore, Rohinton S.
    Gardner, Sharon
    Thomas, Chase
    Cartaxo, Rodrigo
    Yadav, Viveka Nand
    Chi, Andrew
    Kurz, Sylvia
    Wen, Patrick
    Arrillaga-Romany, Isabel
    Batchelor, Tracy
    Butowski, Nicholas
    Sumrall, Ashley
    Shonka, Nicole
    Harrison, Rebecca
    de Groot, John
    Mehta, Minesh
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Cloughesy, Timothy
    Ellingson, Benjamin
    Umemura, Yoshie
    Garton, Hugh
    Franson, Andrea
    Robertson, Patricia
    Schwartz, Jonathan
    Cantor, Evan
    Miklja, Zachary
    Mullan, Brendan
    Bruzek, Amy
    Siada, Ruby
    Cummings, Jessica
    Paul, Alyssa
    Wolfe, Ian
    Jiang, Li
    Filbin, Mariella
    Vats, Pankaj
    Kumar-Sinha, Chandan
    Mody, Rajen
    Chinnaiyan, Arul
    Venneti, Sriram
    Lu, Guangrong
    Mueller, Sabine
    Martinez, Daniel
    Resnick, Adam
    Nazarian, Javad
    Waszak, Sebastian
    Allen, Joshua
    Koschmann, Carl
    NEURO-ONCOLOGY, 2020, 22 : 45 - 46
  • [33] PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA.
    Jackson, Evangeline
    Duchatel, Ryan
    Persson, Mika
    Mannan, Abdul
    Yadavilli, Sridevi
    Parackal, Sarah
    Game, Shaye
    Chong, Wai Chin
    Jayasekara, Samantha
    Le Grand, Marion
    Kearney, Padraic
    Douglas, Alicia
    Findlay, Izac
    Staudt, Dilana
    Germon, Zacary
    Skerrett-Byrne, David
    Nixon, Brett
    Smith, Nathan
    Hulleman, Esther
    Day, Bryan
    McCowage, Geoffrey
    Alvaro, Frank
    Waszak, Sebastian
    Larsen, Martin
    Colino-Sanguino, Yolanda
    Valdes-Mora, Fatima
    Rakotomalala, Andria
    Meignan, Samuel
    Pasquier, Eddy
    Vitanza, Nicholas
    Nazarian, Javad
    Koschmann, Carl
    Cain, Jason
    Mueller, Sabine
    Dun, Matthew
    NEURO-ONCOLOGY, 2022, 24 : 211 - 211
  • [34] Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort
    Odia, Yazmin
    Hall, Matthew D.
    Cloughesy, Timothy Francis
    Wen, Patrick Y.
    Arrillaga-Romany, Isabel
    Daghistani, Doured
    Mehta, Minesh P.
    Tarapore, Rohinton S.
    Ramage, Samuel C.
    Allen, Joshua E.
    NEURO-ONCOLOGY, 2024, 26 : S165 - S172
  • [35] Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone ONC201 in Hematological Malignancies In Vitro and In Vivo through Apoptosis Via the Integrated Stress Response Pathway
    Prabhu, Varun Vijay
    Talekar, Mala Kiran
    Lulla, Amriti R.
    Kline, C. Leah B.
    Zhou, Lanlan
    Hall, Junior
    Van den Heuvel, A. Pieter J.
    Dicker, David T.
    Grupp, Stephan A.
    Garnett, Mathew
    McDermott, Ultan
    Benes, Cyril H.
    Pu, Jeffrey J.
    Claxton, David F.
    Oster, Wolfgang
    Allen, Joshua E.
    El-Deiry, Wafik S.
    BLOOD, 2017, 130